UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Advanced colorectal cancer: Exploring treatment boundaries
Hompes, D.N.M.
Publication date 2013
Link to publication
Citation for published version (APA):
Hompes, D. N. M. (2013). Advanced colorectal cancer: Exploring treatment boundaries.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.
Contents:
I. General introduction and outline of the thesis
II. Neo-adjuvant treatment for metastatic disease of colorectal origin
1. Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience.
Hompes D, Boot H, van Tinteren H, Verwaal V.
Unresectable peritoneal carcinomatosis from
colorectal cancer: a single center experience. J Surg Oncol 2011; 104: 269-273.
2. Neo-adjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer: a prospective pilot study.
Hompes D, Aalbers A, Boot H, van Velthuysen ML, Vogel W, Verwaal V. Neo-adjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer: a prospective pilot study. Submitted to Ann Surg Oncol.
3. Review: Incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events.
Hompes D, Ruers T. Review: Incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events. Eur J Surg Oncol 2011; 37: 737-746.
III. Cytoreductive surgery and HIPEC for peritoneal carcinomatosis of colorectal origin 1. The Treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intra-peritoneal peroperative chemotherapy (HIPEC) with Oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Kerger J, Legendre H. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intra-peritoneal peroperative chemotherapy (HIPEC) with Oxaliplatin: a Belgian multicentre prospective observational clinical study. Ann Surg Oncol 2012; 19: 2186-2194.
2. The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.
Hompes D D’Hoore A, Mirck B, Fieuws S, Bruijn S, Verwaal V. The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. Submitted to Eur J Surg Oncol.
3. HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?
Hompes D, Tiek J, Wolthuis A, Fieuws S, PenninckxF, Van Cutsem E, D’Hoore A. HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol 2012; 23: 3123-3129.
IV. RFA in colorectal liver metastases treatment
1. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin.
Hompes D, Prevoo W, Ruers T. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging 2011; 24: 23-30. Review.
2. Morbidity and mortality of laparoscopic vs. open radiofrequency ablation for hepatic malignancies.
Topal B, Hompes D, Aerts R, Fieuws S, Thijs M, Penninckx F. Morbidity and mortality of laparoscopic vs. open radiofrequency ablation for hepatic malignancies. Eur J Surg Oncol 2007; 33: 603-607.
3. Laparoscopic liver resection using
radiofrequency coagulation.
Hompes D, Aerts R, Penninckx F, Topal B. Laparoscopic liver resection using radiofrequency coagulation. Surg Endosc 2007; 21: 175-180.
V. General Discussion
VI. Conclusions
Acknowledgments
